Bloomberg Markets & Finance via Youtube

Nov.18 — Pfizer Inc. and BioNTech SE will apply later this week for U.S. regulatory authorization of their coronavirus vaccine, which should bring about vaccinations by the end of the year, says Vanderbilt University School of Medicine Professor William Schaffner. He speaks on “Bloomberg Markets: European Close.”

READ ALSO  SE: U.S. Dollar to Weaken Into 2021, Says JPMorgan AM’s Callegari